Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

mClinica enters the doctor’s office with strategic investment in Medix

Image

21-Apr-15 Singapore-based healthtech start-up mClinica has acquired a stake in cloud-based clinic management service Medix for an undisclosed sum. By partnering with mClinica, which maintains digital networks of pharmacies across Asia, Medix will gain operational expertise and access to mClinica’s client base, which includes some of the world’s largest healthcare companies. [image: Tech In Asia]

Read More

Singapore, Korea tie up to train medical technologies talent

Image

29-Apr-15 Singapore-Stanford Biodesign (SSB) and Dongguk University (DU) have inked a three-year "SSB-Korea Innovation Partnership" (SKIP) which will develop talent in medical technologies innovation. It also aims to gain insights into the medtech ecosystems in Singapore, Korea as well as the region. [image: The Straits Times]

Read More

Taiwan’s Apex Medical forays into Indian healthcare market

Image

06-May-15 Taiwan’s Apex Medical Corp is foraying into India to tap the growing healthcare market and plans to sell ‘quality and affordable’ equipment to hospitals and nursing homes. “We chose India... because it has a huge population and a new government that is willing to make a big change,” Daniel Lee, CEO, Apex Medical Corp, told reporters. [image: Apex Medical Corp]

Read More

China lifts price control on most medicines

Image

06-May-15 China will lift price controls on most medicines starting from Jun-15, following which medicine prices will be decided by the market, the National Development & Reform Commission (NDRC) has said. Only narcotics and some listed psychotropic drugs will continue to be controlled by the government, with ceiling retail prices. [image: AFP Photo / Anthony Wallace]

Read More

Bayer making deep inroads across China

Image

06-May-15 Bayer HealthCare reaffirmed its strong position in China's healthcare industry with sales of EUR1.7 bn (USD1.9 bn) in 2014, 14% up on 2013. Its pharmaceuticals business grew at 15% in China, with a 26% spike in its consumer care business and 11% growth in its animal healthcare division. [image: China Daily]

Read More
Share

 


0111 Banner square pre launch 250x250